[EN] INHIBITING HUMAN INTEGRIN A4B7<br/>[FR] INHIBITION DE L'INTÉGRINE HUMAINE A4B7
申请人:[en]MORPHIC THERAPEUTIC, INC.
公开号:WO2022081983A1
公开(公告)日:2022-04-21
Disclosed are small molecule antagonists of human α4β7integrin, and methods of using them to treat a number of diseases and conditions.